Collaboration will focus on the development of smart neurostimulators for the treatment of severe chronic diseases
News
Kuano raises £1m to further develop AI drug discovery platform
Company is aiming to transform the discovery of therapeutics focused on enzyme inhibition
AZ, Amgen’s asthma med tezepelumab gains FDA priority review
Priority review comes following positive results from the Phase III NAVIGATOR trial
Keytruda gains expanded US approval in skin cancer
Checkpoint inhibitor has been approved to treat locally advanced cutaneous squamous cell carcinoma
‘What’s next for patient advocacy?’ Leaders share lessons of Patient Partnership Index 2021 at free virtual event
During the event, the panel explored how partnerships innovated in the face of challenges
Newly introduced Health and Care Bill aims to ‘dispose of unnecessary bureaucracy’
Bill has been formally introduced to Parliament this week
Jardiance becomes first SGLT2 inhibitor to show benefit in HFpEF
Eli Lilly and Boehringer Ingelheim have revealed positive results from a Phase III study of Jardiance in HFpEF patients
Gov’t sets out ten-year strategy for the UK’s life sciences sector
New ‘Life Sciences Vision’ outlines seven critical healthcare missions
Gov’t announces £2.45m funding to improve maternity safety
Almost £2m will be used for the first phase of the Avoiding Brain Injuries in Childbirth collaboration
BMA calls for some COVID-19 measures to remain after 19 July
Doctors’ union urges reconsideration of government plans to ditch mandatory wearing of facemasks
Oxford researchers launch HIV vaccine trial
Vaccine will be evaluated in 13 HIV-negative adults aged 18-65 years old
EC clears AstraZeneca’s acquisition of Alexion
Clearance in the UK is still pending and remains a requirement to complete the proposed deal
Spaces still available in the 2021 Marketer of the Year competition
Entries for the 2021 competition are well underway and PharmaTimes are calling on pharma marketers in a variety of roles to step forward and enter.
Merck KGaA and BioMed X launch new joint cancer research programme
New partnership will explore the role of extrachromosomal DNA in cancer
GSK and Alector ink neurodegenerative diseases partnership
Under the terms of the collaboration, Alector could receive up to $1.5bn in milestone payments
